[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-357061-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-357061-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mir-130a-3p-regulates-the-occurrence-and-progression-of-lung-squamous-cell-carcinoma-by-activating-zdhhc5-and-immune-cell-related-pathways","miR-130a-3p regulates the occurrence and progression of lung squamous cell carcinoma by activating ZDHHC5 and immune cell-related pathways","","Prior investigations highlight palmitoylation as a key process in the onset and progression of cancers, yet its upstream and downstream regulatory networks in lung squamous cell carcinoma (LUSC) remain insufficiently defined. This study used Mendelian randomization and multiple validation layers—2-sample MR, SMR, differential gene expression, meta-analysis, single-cell analyses, and mediation assessment—to map mechanisms linking microRNAs, palmitoylation genes, and immune-cell interactions. Elevated ZDHHC5 increased LUSC risk, and miR-130a-3p mediated these effects via ZDHHC5 and CD28 on secreting Tregs.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mir-130a-3p-regulates-the-occurrence-and-progression-of-lung-squamous-cell-carcinoma-by-activating-zdhhc5-and-immune-cell-related-pathways/357061/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mir-130a-3p-regulates-the-occurrence-and-progression-of-lung-squamous-cell-carcinoma-by-activating-zdhhc5-and-immune-cell-related-pathways/357061.png","ImageObject",300,407,{"name":42,"@type":43},"Grenda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main regulatory relationship proposed for miR-130a-3p in LUSC?","Question",{"text":63,"@type":64},"miR-130a-3p indirectly influences LUSC development by modulating ZDHHC5 gene expression, which then affects immune-cell related mechanisms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does ZDHHC5 relate to lung squamous cell carcinoma risk?",{"text":68,"@type":64},"Higher ZDHHC5 expression showed a notable positive association with increased LUSC risk, with a stated 1 SD increase corresponding to a 22.90% rise in risk.",{"name":70,"@type":61,"acceptedAnswer":71},"Which immune-cell factor is implicated in the mediation analysis?",{"text":72,"@type":64},"Mediation analysis identified CD28 on secreting regulatory T cells (Treg) as an intermediary, with a reported mediation effect ratio of 16.59% (P = .033).","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},357061,1790359749,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","®  \n Observational Study   \nmiR-130a-3p regulates the occurrence and progression of lung squamous cell carcinoma by activating ZDHHC5 and immune cell-related pathways  \nWenhao Li, MMa , Binxue Xia, MMb , Shukai Deng, MMb ,*  \n\n| Abstract\u003Cbr>Prior investigations have indicated that the process of palmitoylation is crucial in the onset and progression of a variety of cancers. Nonetheless, its function in lung squamous cell carcinoma (LUSC) and the corresponding upstream and downstream regulatory networks remains inadequately explored. In this research, we aimed to elucidate the causal links and underlying mechanisms among microRNAs (miRNAs), palmitoylation‐related genes, immune cell interactions, and LUSC using Mendelian randomization (MR) approaches. The study integrated 2-sample MR analysis, SMR analysis, differential gene expression examination, metaanalysis, single-cell investigation, and mediation assessment. Two-sample MR was employed to evaluate the causal impact of palmitoylation-associated genes on LUSC development, while SMR techniques and single-cell analyses were utilized to validate the association between gene expression patterns and LUSC. A notable positive association was observed between elevated expression levels of the ZDHHC5 gene and increased LUSC risk. Specifically, an increment of 1 standard deviation in ZDHHC5 expression corresponded to a 22 .90% rise in LUSC risk. These findings were corroborated by differential gene expression analysis, meta-analysis, and validation at the single-cell level. Additional miRNA analysis revealed that miR-130a-3p indirectly influences LUSC development by modulating ZDHHC5 gene expression, with a mediation effect ratio of 95 .67%(P = .038) . Further mediation analysis explored the intermediary role of immune cells in the relationship between ZDHHC5 and LUSC, identifying CD28 on secreting regulatory T cells (Treg) with a mediation effect ratio of 16.59%(P = .033) . The data indicate that miR-130a-3p exerts regulatory control over the ZDHHC5 gene, consequently modulating the function of CD28 on secreting Tregs, thereby promoting LUSC occurrence. These insights provide a novel theoretical foundation for the development of immunotherapeutic and targeted treatment strategies for LUSC.\u003Cbr>Abbreviations: AC = absolute cell count, ASO = antisense oligonucleotide, ASO = antisense oligonucleotide, BRCA = breast carcinoma, CAF = cancer-associated fibroblast, CD28 = cluster of differentiation 28, CTLA-4 = cytotoxic T-lymphocyte-associated protein 4, eQTL = expression quantitative trait loci, ERK = extracellular signal-regulated kinase, ESCA = esophageal carcinoma, EZH2 = enhancer of Zeste homolog 2, FAK = focal adhesion kinase, GBM = glioblastoma, GWAS = genome-wide association study, HEIDI = heterogeneity in dependent instruments, IL-10 = interleukin-10, ILCCO = International Lung Cancer Consortium, IV = instrumental variable, IVW = inverse variance weighting, LIHC = liver hepatocellular carcinoma, LUAD = lung adenocarcinoma, LUSC = lung squamous cell carcinoma, MAPK = mitogen-activated protein kinase, MFI = median fluorescence intensity, miReQTL = microRNA expression quantitative trait loci, miRNA = microRNA, MP = morphological parameter, MR = Mendelian randomization, Oct4 = octamer-binding transcription factor 4, PD-1 = programmed cell death protein 1, PD-L1 = programmed death-ligand 1, PERL-CGI = practical extraction and report language – common gateway interface, RC = relative cell count, SAL = surface antigen level, scRNA-seq = single-cell RNA sequencing, SMD = standardized mean difference, SMR = summary databased Mendelian randomization, SNP = single nucleotide polymorphism, TBNK = T cells, B cells, and natural killer cells, TCGA = the cancer genome atlas, TGF-β = transforming growth factor beta, TISCH = tumor immune single-cell hub, Treg = regulatory T cell, TRICL = transdisciplinary research in cancer of the lung, UTR = untranslated region. |\n| --- |\n| Keywords: immune cells, l","cbCaigGirnjXdT71","https://ap.wps.com/l/cbCaigGirnjXdT71","pdf",1519703,"English","# Introduction\n## Study rationale and background\n## Mendelian randomization framework\n## Gene-expression validation and immune-cell mediation","[{\"question\":\"What is the main regulatory relationship proposed for miR-130a-3p in LUSC?\",\"answer\":\"miR-130a-3p indirectly influences LUSC development by modulating ZDHHC5 gene expression, which then affects immune-cell related mechanisms.\"},{\"question\":\"How does ZDHHC5 relate to lung squamous cell carcinoma risk?\",\"answer\":\"Higher ZDHHC5 expression showed a notable positive association with increased LUSC risk, with a stated 1 SD increase corresponding to a 22.90% rise in risk.\"},{\"question\":\"Which immune-cell factor is implicated in the mediation analysis?\",\"answer\":\"Mediation analysis identified CD28 on secreting regulatory T cells (Treg) as an intermediary, with a reported mediation effect ratio of 16.59% (P = .033).\"}]","miR-130a-3p regulates the occurrence and progression of lung squamous cell carcinoma by activating ZDHHC5 and immune cell-related pathways | PDF",1790128772,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7cce59f2afc08edcf08503d2fce65f90.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cae9c45f41d48e580d94fb9e0bcae4d4.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57dc2d55af76438179ceedf52d03a69c.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9abfb17c04c0b9ef546d7aa04848508f.webp",980,1306]